Skip to main content
Caplight Logo









Ribbon Bio

Ribbon Bio

Private
ViennaHealthcare & Life Scienceshttps://ribbonbio.com/

Last Round

Series A

Jan 31, 2022

Total Funding Raised

$21.86M

Company Overview

Ribbon Bio is a synthetic biology company that provides an automated, enzyme-based technology platform for the synthesis of long and complex DNA molecules.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

synthetic DNAlong DNA synthesisenzymatic DNA synthesisgene synthesissynthetic biologysynbiocomplex DNA synthesisDNA printingDNA manufacturingDNA as a Servicecustom DNA synthesisDNA synthesis servicegene therapyvaccine developmentfee-for-serviceantibody development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ribbon Bio Comparables

Compare Ribbon Bio with similar companies based on industry and business-model similarity.

Ribbon Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ansa Biotechnologies
87%
NunaBio Limited
84%
Synplogen Co., Ltd.
84%

Ribbon Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 31, 2022
Pre SeedMar 8, 2019

Ribbon Bio Investors

Notable investors and investment history

Ribbon Bio investors
InvestorRounds
tecnet equityPre Seed, Series A
Vienna Business AgencyGrant
Austria WirtschaftsserviceGrant, Pre Seed
xista science venturesPre Seed, Series A
European CommissionGrant
FFG Austrian Research Promotion AgencyGrant
Helicase VentureSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 21, 2026

    Monthly visitors increased 142% MoM.

  • Jan 22, 2025

    Grew 16% QoQ from 45 to 52 employees.

Ribbon Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ribbon Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ribbon Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersVienna
Employee Range56
Year Founded2018
Last FundingJan 31, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?